21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
13.95.Z - Production of nonwoven fabrics and products made from nonwoven fabrics
17.29.Z - Paper and paper product manufacturing
20.42.Z - Manufacture of cosmetics and toilet preparations
20.59.Z - Manufacture of other chemical products, not elsewhere classified
22.29.Z - Manufacture of rubber and plastic products
23.14.Z - Production of glass fibers
23.91.Z - Production of abrasives
32.50.Z - Production of medical devices, instruments, and products, including dental products
72.19.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 42 | 33,8 | 78,8 | 133,4 |
EBITDA | 72 | 56,6 | 85,7 | 51,4 |
Short time liabilities | 109,5 | 94,1 | 126,4 | 34,3 |
Equity capital | 534,9 | 564,4 | 101,9 | -81,9 |
Operating profit (EBIT) | 44,2 | 27,4 | 59,4 | 117 |
Assets | 657 | 666,5 | 231,2 | -65,3 |
Net profit (loss) | 34,2 | 29,5 | 63,3 | 114,1 |
Cash | 31,6 | 30,1 | 2,9 | -90,2 |
Net income from sale | 801,8 | 748,4 | 717,2 | -4,2 |
Liabilities and provisions for liabilities | 122,1 | 102,1 | 129,3 | 26,6 |
Working assets | 438,4 | 456 | 189,3 | -58,5 |
Depreciation | 27,9 | 29,2 | 26,3 | -10 |
% | % | % | p.p. | |
Profitability of capital | 6,4 | 5,2 | 62,1 | 56,9 |
Equity capital to total assets | 81,4 | 84,7 | 44,1 | -40,6 |
Gross profit margin | 5,2 | 4,5 | 11 | 6,5 |
EBITDA Margin | 9 | 7,6 | 12 | 4,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 50 | 46 | 64 | 18 |
Current financial liquidity indicator | 4.002366065979004 | 4.8471999168396 | 1.4982575178146362 | -3,3 |
Net dept to EBITDA | -0.437229722738266 | -0.5263638496398926 | -0.03409748896956444 | 0,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane